Skip to Main Content

Focus on Research

Dr. Tagaya

The USF Health Institute for Translational Virology and Innovation (ITVI) conducts foundational science to uncover how viruses and bacteria drive cancer, chronic disease, and immune dysfunction. Active research spans HIV, HTLV-1, microbial oncogenesis, and HIV molecular biology, with growing programs focused on HPV, Epstein-Barr virus (EBV), hepatitis viruses, respiratory pathogens, and arboviruses such as dengue and Zika. 

The Institute emphasizes cross-disciplinary collaboration, cutting-edge molecular research, and translation of findings into diagnostics, treatments, and public health interventions.

Currently Active Research Units

Planned and Expanding Research Areas

    • Planned Unit
    • Focus: HPV-associated malignancies and immune mechanisms of viral persistence
    • Planned Unit
    • Focus: EBV-driven cancers such as lymphomas and nasopharyngeal carcinoma; identifying latent gene expression patterns and therapeutic targets
    • Planned Unit
    • Focus: Studying mosquito-borne viruses such as dengue, Zika, and chikungunya with a special emphasis on Florida and Latin America; integrating vector surveillance, viral genomics, and outbreak modeling